Latest in Research & Development

BetaGlue Therapeutics gains MHRA approval for pancreatic cancer trial

YntraDose, the innovative radiotherapy treatment for unresectable locally advanced pancreatic cancer, has been granted an early feasibility clinical investigation and will assess safety and performance in patients

Find out more

You need to be a subscriber to read this article.
Click here to find out more.

Addressing the biggest problem in clinical trials with data interoperability and AI

This article discusses how data interoperability and artificial intelligence are transforming clinical trials by streamlining data management, improving analysis accuracy and...
See more

Scottish immunology CRO RoukenBio celebrates 10 years of growth

Formerly known as Antibody Analytics, the contract research organisation has grown from three employees to over 100 and enjoyed successes such as the launch of its first proprietary technology, IndEx-2 and multi-million pound investments

DBV Technologies announces last patient visit completed in Phase III peanut allergy trial in children

The Phase III VITESSE clinical trial of the VIASKIN Peanut patch in peanut allergic children aged 4-7 years remains on track for topline data in Q4 of this year

Medicines Discovery Catapult announces collaboration with £15.9m project on next-gen human disease modelling

The Medical Research Council, Wellcome Trust and Innovate UK will work with MDC to develop advanced, specific and highly reproducible human-based in vitro models of disease, with the aim of making them widely available to researchers in academia and industry

Patient dies in CRISPR gene therapy trial

The FDA has now placed Intellia Therapeutics' Phase III CRISPR trials on hold over raised liver enzymes

Dual inhibition of motor proteins KIF18A and CENP-E shown to selectively kill cancer cells

Researchers from Osaka University and MIT have discovered that blocking two cooperative motor proteins involved in chromosome alignment can trigger cancer cell death, revealing a promising new target for anticancer therapies

EVerZom and GENFIT partner for research collaboration for liver failure candidate EViv

The agreement will support EVerZom’s dynamic development strategy and follows the recent announcement of a €10m financing round aimed at accelerating its clinical and partnering roadmap

Samsung Epis launches subsidiary Epis NexLab for next-gen biotech platform development

Epis NexLab will focus on transforming highly scalable peptide-related technologies into development platforms for the discovery of new drug candidates, including license-out or joint development with global pharmaceutical companies

Aseptic spray drying: Transforming biotherapeutics for a new era

With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications

Latest posts in Research & Development

EazeBio and UC Santa Cruz partner to launch instrument-free diagnostic platform for global health

The pair will co-develop a lab-independent cortisol biosensor, delivering rapid, affordable and AI-guided diagnostics for stress, metabolic health and a range of global health applications

Biohm Technologies expands R&D footprint with new microbiome lab in Atlanta

The company has opened a state-of-the-art research lab at Portal Innovations’ Science Square campus in Atlanta, strengthening its microbiome R&D capabilities

Certain medicines accelerate elimination of PFAS from the body, Gothenburg study shows

Researchers at the University of Gothenburg have found that two cholesterol-lowering drugs, cholestyramine and colesevelam, can significantly speed up the removal of harmful PFAS chemicals from the body

Bioengineered bone marrow model successfully used in cancer research

Scientists at the University of Glasgow have successfully used the first bioengineered bone marrow model in vital leukaemia research

Novo Nordisk's Wegovy results in patients hitting key BMI and waist size targets

New STEP UP trial data show that semaglutide enables people with obesity to achieve BMI and waist-to-height ratio targets linked to lower cardiovascular risk, alongside significant weight loss

Veloxity Labs acquires SCIEX mass spectrometer, the ZenoTOF 8600 System, to accelerate peptide and complex bioanalysis

Veloxity Labs, a bioanalytical CRO built for programmes that need speed with purpose, has announced the acquisition of the ZenoTOF 8600 system from SCIEX, a global leader in life science analytical technologies
You need to be a subscriber to read this article.
Click here to find out more.

Solving the rare disease puzzle

Dan Williams, founder at SynaptixBio, explores the complex challenges of diagnosing and treating rare diseases, their impact on patients and healthcare systems and how small biotech firms are reshaping therapeutic innovation

Lilly partners with NVIDIA to build pharma’s most powerful AI supercomputer for faster drug discovery

Eli Lilly has joined forces with NVIDIA to create the world’s most powerful pharmaceutical supercomputer, designed to accelerate AI-driven medicine discovery and manufacturing — all while running entirely on renewable energy

Jabil and Kymanox collaboration to deliver end-to-end development, regulatory and manufacturing solutions

Jabil and Kymanox are partnering to combine their regulatory, technical, and manufacturing expertise to help life science companies streamline development and bring complex therapies to market faster

Piramal Pharma Solutions formalises partnership with IntoCell

Piramal Pharma Solutions has joined forces with IntoCell to broaden its bioconjugates offering and support innovation in the field

Immunology CRO reports shift to autoimmunity projects

RoukenBio reports a sharp rise in autoimmunity drug development projects and an almost 50% decrease in immuno-oncology (I-O) studies, showcasing the shift in drug development trends

Sponsor content

Abzena advances ADC development with ThioBridge conjugation technology

Next-generation conjugation delivers greater stability, potency and control for targeted cancer therapeutics

Guardtech supporting malaria fight in East Africa with portable 11-bay lab

Suffolk-based experts provide Cleancube Multi 11 for Oxitec’s Friendly mosquito programme in Djibouti

Optimising sample traceability with laser marking technology

Speed and precision in high-throughput tube identification

Flowchem teaching manual now available to download

Guide offers step-by-step instructions for ten reactions including Nobel Prize-winning examples

Cut Argon use and costs with Shimadzu’s ICPMS-2040/2050

New Mini-Torch System offers precision analysis with 40% less Argon

Driving ADC innovation with complex chemistry solutions

Abzena’s tailored chemistry expertise enables scalable, high-quality bioconjugate development from discovery to GMP production

ProImmune Ltd introduces ProVE SL Self-Loading MHC Class I Monomers to improve T cell research flexibility

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers. The novel...

Streamlining bioconjugation for next-generation ADC development

Abzena’s proprietary ThioBridge™ technology delivers precision, scalability, and enhanced stability for antibody-drug conjugates

TurboFil offers industry-leading glove testing systems

Partnership with RAVONA delivers precision and compliance in aseptic environments

How to optimise your quality culture and maturity for success

NSF outlines how aligning culture, leadership and systems can strengthen compliance and performance

Shimadzu launches ALTRACE energy dispersive X-ray fluorescence spectrometer

High-sensitivity analysis and automated measurements for food, environmental, and pharmaceutical inspections

Accelerating self-administration and homecare with large-volume prefillable glass syringe

SCHOTT Pharma launches 5.5 ml syringe compatible with autoinjectors to enable comfortable home injections

Featured companies

CARBOGEN AMCIS is a global Contract Development and Manufacturing Organization (CDMO) providing drug development and commercialization services to the pharmaceutical and... Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or... Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life... Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway for small-molecule and peptide drug...
See more